Research laboratories at the Perkins are organised into the following programs and centres.
Perkins researchers have made major discoveries in the field of cancer including uncovering the SLIRP gene which controls hormone production in breast and prostate cancers, the tumour suppressor gene HLS5 and a process for normalising blood vessels in tumours to allow more effective absorption of cancer-combating drugs.
The Cardiovascular Science and Diabetes Program at the Perkins is focussed on translational research to improve health outcomes. The research teams investigate diseases ranging from heart disease, diabetes, kidney disease and cancer. The program also encompasses the biomedical engineering teams that develop new medical devices.
The Genome Biology and Genetics Program focuses on factors that affect health and well being at the genetic, protein and population levels, with the common aim of improving diagnosis and treatment of disease.
All donations of $2 and over are tax deductible in Australia.
Perkins is registered with the Australian Taxation Office as a Deductible Gift Recipient (DGR): Charitable Fundraising Authority No DGR CC20761
We acknowledge the Whadjuk people of the Nyoongar nation, the traditional owners of the lands where our offices are located and pay respects to their elders, past, present and emerging.
